| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 09/11/2003 | US20030170854 Recombinant human creatine kinase heterodimer with solution-stability |
| 09/11/2003 | US20030170841 Novel molecules of the pyrin domain protein family and uses thereof |
| 09/11/2003 | US20030170840 Genomic mammary amyloid a sequence |
| 09/11/2003 | US20030170839 Type 2 cytokine receptor and nucleic acids encoding same |
| 09/11/2003 | US20030170838 Novel polynucleotides and polypeptides encoded thereby |
| 09/11/2003 | US20030170826 Fusion proteins include cell penetrating domain linked to transmembrane domain |
| 09/11/2003 | US20030170825 Comprises antihemophilic factor (factor VIII) and antitrypsin signal sequences; for treatment of hemophilia |
| 09/11/2003 | US20030170823 Polynucleotide encoding a polypeptide; induces proliferation or cytotoxicity in cells; use in increasing platelets and in detection of cancer, inflammation and genetic abnormalities |
| 09/11/2003 | US20030170822 Fibroblast growth factor-like molecules and uses thereof |
| 09/11/2003 | US20030170818 Methods and materials relating to novel prothrombinase-like polypeptides and polynucleotides |
| 09/11/2003 | US20030170817 Molecule having an antigen binding region specific for an epitope recognized by the antibody produced by the hybridoma; prophylaxis and treatment of apoptosis related conditions |
| 09/11/2003 | US20030170812 Interleukin-1beta converting enzyme like cysteine protease |
| 09/11/2003 | US20030170811 Culturing a microorganism transformed with an expression vector comprising a gene encoding an amino acid sequence of a peptide-fused atriopeptin; use as antihypertensive diuretic agent |
| 09/11/2003 | US20030170807 Expression vectors; use in identifying compound that modulates receptor activated calcium mobilization |
| 09/11/2003 | US20030170792 MAGE-3 peptides presented by HLA class ll molecules |
| 09/11/2003 | US20030170790 Of given amino acid sequence; use in modulating cell activity, stimulating release of tumor necrosis factor, proteoglycans and cytokines; detecting tumors |
| 09/11/2003 | US20030170789 Of given amino acid sequence; use in modulating cell activity, stimulating release of tumor necrosis factor, proteoglycans and cytokines; detecting tumors |
| 09/11/2003 | US20030170788 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 09/11/2003 | US20030170784 Secreted proteins and uses thereof |
| 09/11/2003 | US20030170783 Method to extend the life span of normal cells |
| 09/11/2003 | US20030170779 Novel G protein-coupled receptors |
| 09/11/2003 | US20030170777 An isolated nucleic acid molecule that encodes the amino acid sequence, cell culturing, binding to antibody, non-human transgenic animal, antithrombotic drugs, treating cardiovascular diseases, genetic engineering |
| 09/11/2003 | US20030170776 Antiinflammatory agents; kidney diseases; anticancer agents |
| 09/11/2003 | US20030170766 Methods and compositions for inhibiting farnesyl transferase enzyme |
| 09/11/2003 | US20030170759 Detection, monitoring ovarian tumors; using enzyme inhibitor |
| 09/11/2003 | US20030170752 Prevention of breast cancer |
| 09/11/2003 | US20030170750 Urogenital carcinoma tlp complex peptides and antibodies thereof |
| 09/11/2003 | US20030170743 Determination sensitivity; administering gene moderators |
| 09/11/2003 | US20030170736 Adjustment of cell differentiation; medical diagnosis |
| 09/11/2003 | US20030170729 Process for the measurement of the potency of glatiramer acetate |
| 09/11/2003 | US20030170727 Drug screening; cental nervous system disorders |
| 09/11/2003 | US20030170721 Bonding to antibodies; genetic engineering |
| 09/11/2003 | US20030170718 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 09/11/2003 | US20030170714 Polypeptides; activation lymphocytes |
| 09/11/2003 | US20030170704 Therapy for central nervous system disorders; Alzheimer's disease; cells transfected with Dna |
| 09/11/2003 | US20030170685 Canine hepatocyte growth factor |
| 09/11/2003 | US20030170679 Hybrid growth hormone |
| 09/11/2003 | US20030170671 Novel human G-protein coupled receptor, HGPRBMY6, expressed highly in small intestine |
| 09/11/2003 | US20030170663 Nucleotide sequence of the Mycoplasma genitalium genome, fragments thereof, and uses thereof |
| 09/11/2003 | US20030170658 Genetic engineered retroviruses; detecting antigen, antibody complex; medical diagnosis |
| 09/11/2003 | US20030170655 Mus101 and homologue thereof |
| 09/11/2003 | US20030170648 Autoimmune diseases; inflammatory bowel disease; multiple sclerosis; rheumatic diseases; modulate gene expression |
| 09/11/2003 | US20030170647 Nucleic acid encoding a retinoblastoma binding protein (RBP-7) and polymorphic markers associated with said nucleic acid |
| 09/11/2003 | US20030170643 Regulation of apoB treatment and drug screening for cardiovascular and metabolic disorders or syndromes |
| 09/11/2003 | US20030170636 Controlling cell differentiation |
| 09/11/2003 | US20030170630 Proteins and nucleic acids encoding same |
| 09/11/2003 | US20030170628 Forsenic analysis; medical diagnosis; chromosome markers |
| 09/11/2003 | US20030170621 Polypeptide which modulate cellular response |
| 09/11/2003 | US20030170620 Gene controlling androgen |
| 09/11/2003 | US20030170616 Diagnosis using antibodies; genetic engineering |
| 09/11/2003 | US20030170307 Inorganic-polymer complexes for the controlled release of compounds including medicinals |
| 09/11/2003 | US20030170297 Lipid-based drug delivery systems containing phospholipase a2 degradable lipid derivatives for topical application to the skin |
| 09/11/2003 | US20030170289 Injectable depot compositions and uses thereof |
| 09/11/2003 | US20030170276 Modified msbB gene |
| 09/11/2003 | US20030170273 Type 1 interferon inducers, such as double-stranded RNA, in combination with antigen delivery systems and/or immunostimulatory molecules for enhancing the immune response of a coadministered antigen |
| 09/11/2003 | US20030170270 Nucleic acid encoding an infectious, nonpathogenic PCV1, which contains an immunogenic open reading frame gene of a pathogenic PCV2 in place of an ORF gene of the PCV1 nucleic acid molecule. |
| 09/11/2003 | US20030170269 Vaccine for mystery swine disease and method for diagnosis thereof |
| 09/11/2003 | US20030170268 Administering a fusion protein of a heat shock protein or immunostimulatory fragment and a human papilloma virus protein or an antigenic fragment; or a nucleic acid coding the fusion protein |
| 09/11/2003 | US20030170263 Expression system |
| 09/11/2003 | US20030170262 Immunogenic detoxified mutant E. coli LT-A toxin |
| 09/11/2003 | US20030170261 From Neisseria meningitidis; attenuated microorganismsthat have a reduced ability to take up DNA; vaccines |
| 09/11/2003 | US20030170255 Compositions and methods for the therapy and diagnosis of lung cancer |
| 09/11/2003 | US20030170253 Useful in stimulating angiogenesis as well as in diagnostic applications. |
| 09/11/2003 | US20030170252 Also a hybridoma cell capable of producing the antibody; anticancer agents |
| 09/11/2003 | US20030170248 Constant region contains a human immunoglobulin and variable region contains a non-human immunoglobulin variable region; especially treating an infection caused by Enterohemorrhagic Escherichia coli |
| 09/11/2003 | US20030170246 Fusion protein, comprising a first lipophilin-like polypeptide linked by a peptide bond to a second lipophilin-like polypeptide; polynucleotides encoding the protein; antibodies; especially for breast, ovarian or prostate cancer. |
| 09/11/2003 | US20030170244 CD95 antigen induced apoptosis to treat bone marrow failure and to improve cancer therapies. |
| 09/11/2003 | US20030170243 Use of human plasma hyaluronidase in cancer treatment |
| 09/11/2003 | US20030170242 Novel isoforms of vascular endothelial cell growth inhibitor |
| 09/11/2003 | US20030170240 Composition of an endogenous insulin-like growth factor-II derivative |
| 09/11/2003 | US20030170237 G-CSF receptor agonist antibodies and screening method therefor |
| 09/11/2003 | US20030170234 Combination of the antibody and a chemotherapeutic agent other than an anthracycline, e.g. doxorubicin or epirubicin; treating cancer |
| 09/11/2003 | US20030170233 Treating Autoimmune Diseases with Humanized Anti-CD40L Antibody |
| 09/11/2003 | US20030170227 Administering a casomorphinase or a casomorphin ligand microbial casomorphin inhibitor and a gluteomorphinase or a gluteomorphin ligand gluteomorphin inhibitor |
| 09/11/2003 | US20030170226 Compositions and methods relating to reduction of symptoms of autism |
| 09/11/2003 | US20030170225 Method of enhancing the effect of collagenase on wounds |
| 09/11/2003 | US20030170224 Disorders are prevented without causing toxic damage to said mammalian eye. |
| 09/11/2003 | US20030170223 Pulmonary vasodilator surfactant compositions and method of use |
| 09/11/2003 | US20030170221 For producing fibrinolytic enzyme actinokinase; efficiency |
| 09/11/2003 | US20030170220 For inhibiting growth of prostatic adenocarcinoma, stomach cancer, breast cancer, endometrial, ovarian or other cancers of epithelial secretion, or benign prostate hyperplasia |
| 09/11/2003 | US20030170219 For diagnosing and treating disorders associated with expression of human disease associated protein kinases |
| 09/11/2003 | US20030170215 Encapsulating a cell culture of propagating pancreatic cells; inserting the encapsulated cells into the mammal permitting the cells to mature to insulin secreting cells |
| 09/11/2003 | US20030170213 Methods and compositions for enhancing cognitive function using morphogenic proteins |
| 09/11/2003 | US20030170211 For delivering alphavirus replicon DNA into an animal or animal cells with the replicon encoding one or more heterologous genes to be expressed in the animal or the animal cells |
| 09/11/2003 | US20030170209 Use of a vector comprising a nucleic acid coding for an anti-angiogenic factor for treating corneal neovascularization |
| 09/11/2003 | US20030170208 To promote osteogenesis and therefore uses include fracture healing and repair and acceleration of fracture healing |
| 09/11/2003 | US20030170207 For therapy of viral, tumorous and immune diseases |
| 09/11/2003 | US20030170206 Interferon beta-like molecules |
| 09/11/2003 | US20030170205 For modulating the proliferation, differentiation, migration, or metabolism of mesencymal cells in an animal |
| 09/11/2003 | US20030170204 To enhance in vivo tumour regression activity of the TNF |
| 09/11/2003 | US20030170203 Death domain containing receptors |
| 09/11/2003 | US20030170201 Polymeric micelle containing cisplatin enclosed therein and use thereof |
| 09/11/2003 | US20030170184 Administering to a mammal in need of such treatment a lactic bacteria strain that is exogenous to oral microflora, which strain is selected for its ability to adhere to teeth pellicle and to produce a growth inhibition factor |
| 09/11/2003 | US20030170178 For therapy and diagnosis of infectious diseases; diseases characterised by cellular hyperproliferation such as tumours, psoriasis, actinic keratosis, atheromas, endoarterial hyperplasia, prostate hyperplasia; for sterilization of blood |
| 09/10/2003 | EP1342796A2 Compound for the treatment of paget's disease of bone |
| 09/10/2003 | EP1342783A1 An active VEGF being resistant to proteolysis |
| 09/10/2003 | EP1342779A1 Means and methods for manipulating hypersensitivity-like responses |
| 09/10/2003 | EP1342730A1 Fusion protein having the enhanced in vivo activity of erythropoietin |
| 09/10/2003 | EP1342729A2 Antibodies and antisense molecules for G-coupled receptor showing selective affinity for ATP |
| 09/10/2003 | EP1342489A1 Method of affecting sleep and sleep-related behaviors |